Skip to main content

Rural Americans Are Going Without Meds to Fight Opioid, Alcohol Addictions

Medically reviewed by Carmen Pope, BPharm. Last updated on March 26, 2024.

By Carole Tanzer Miller HealthDay Reporter

TUESDAY, March 26, 2024 — Less than 9% of rural Americans who abuse both opioids and alcohol are prescribed medications to treat both disorders, new research reveals.

Naltrexone treats both opioid use disorder and alcohol use disorder. Other drugs such as buprenorphine, acamprosate or disulfiram treat one or the other.

And researchers who reviewed medical records of close to 1,900 adults who visited a rural primary care provider between October 2019 and January 2021 found that most with a dual diagnosis were being treated for only one disorder, not both.

The new study findings "call for a better understanding of these gaps as well as additional support for rural clinicians in providing pharmacological treatment," wrote the team headed by Emily Kan of the University of California, Los Angeles.

In all, 85.3% of patients with a dual disorder were prescribed a medication for only one condition, compared to patients struggling with opioid use only (63.7%) or those battling alcohol issues only (10.3%), the study found.

Those with a dual diagnosis spent the most time on medication — about 265 days — compared to those with opioid disorder alone (220.5 days) or alcohol disorder alone (62.5 days).

Overall, 54.2% of the patients had opioid use disorder only; 37.9% alcohol use disorder only; and 7.9% had both.

"The low rates of naltrexone prescription are concerning given the current evidence of the effectiveness of extended release-naltrexone in treating both disorders," the researchers wrote.

They said primary care practices in rural areas need help assessing and treating the disorders and also with providing telemedicine to deliver care remotely.

The findings were recently published in the Journal of Substance Use and Addiction Treatment.

Sources

  • American Psychiatric Association, news release, March 22, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

Drug, Alcohol Abuse Goes Untreated in Many Ex-Prisoners

THURSDAY, April 25, 2024 -- Most ex-cons are unlikely to receive substance use treatment following their release from prison, even though odds are high they are struggling with...

Few Young Adults Could Administer Naloxone to Reverse Fentanyl Overdose

MONDAY, April 22, 2024 -- Even though fentanyl-linked fatal overdoses are soaring among young adults, a new survey of American college students found that just 1 in 7 knew how to...

Black and Native Americans Hit Hardest by 'Deaths of Despair'

WEDNESDAY, April 10, 2024 -- More middle-aged Black and Native Americans are now falling prey to “deaths of despair” than whites, a new study finds. These deaths --...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.